Skip to main content
Fig. 5 | Journal of Inflammation

Fig. 5

From: Zymosan attenuates melanoma growth progression, increases splenocyte proliferation and induces TLR-2/4 and TNF-α expression in mice

Fig. 5

The viability and proliferation of murine splenocytes ex-vivo is increased concentration-dependently by zymosan treatment. Panel a represents the viability of splenocytes after 72 h treatment with different concentrations of zymosan as determined by MTT assay. Panel b represents number of splenocytes as measured by trypan blue exclusion assay when treated for 72 h with increasing concentrations of zymosan. Panel c represents the correlation between splenocyte viability and proliferation. The data are reported as the means ± SD of at least 3 independent experiments. *P < 0.05 compared with control splenocytes not treated with zymosan

Back to article page